USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$140.61M
Market Cap
-
P/E Ratio
-0.95
EPS
$1.80
52 Week High
$0.73
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$3.9M |
Total Revenue | $4.3M |
Cost Of Revenue | $8.3M |
Costof Goods And Services Sold | $8.3M |
Operating Income | -$46M |
Selling General And Administrative | $20B |
Research And Development | $6M |
Operating Expenses | $42M |
Investment Income Net | - |
Net Interest Income | $296K |
Interest Income | $322K |
Interest Expense | $26K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$46M |
Income Tax Expense | $7.5B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$46M |
Comprehensive Income Net Of Tax | - |
Ebit | -$46M |
Ebitda | -$44M |
Net Income | -$46M |
Field | Value (USD) |
---|---|
Total Assets | $31M |
Total Current Assets | $25M |
Cash And Cash Equivalents At Carrying Value | $22M |
Cash And Short Term Investments | $22M |
Inventory | $341K |
Current Net Receivables | $405K |
Total Non Current Assets | $5.6M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $736K |
Intangible Assets Excluding Goodwill | $736K |
Goodwill | $735M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2M |
Other Non Current Assets | - |
Total Liabilities | $25M |
Total Current Liabilities | $24M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $19M |
Total Non Current Liabilities | $1.8M |
Capital Lease Obligations | $2.7M |
Long Term Debt | - |
Current Long Term Debt | $19M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $21M |
Other Current Liabilities | $2.8M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $5.4M |
Treasury Stock | - |
Retained Earnings | -$204M |
Common Stock | $63K |
Common Stock Shares Outstanding | $51M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$44M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.2M |
Capital Expenditures | $646K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$646K |
Cashflow From Financing | $48M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $447M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$46M |
Field | Value (USD) |
---|---|
Gross Profit | -$3.9M |
Total Revenue | $4.3M |
Cost Of Revenue | $8.3M |
Costof Goods And Services Sold | $8.3M |
Operating Income | -$46M |
Selling General And Administrative | $20B |
Research And Development | $6M |
Operating Expenses | $42M |
Investment Income Net | - |
Net Interest Income | $296K |
Interest Income | $322K |
Interest Expense | $26K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | -$46M |
Income Tax Expense | $7.5B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$46M |
Comprehensive Income Net Of Tax | - |
Ebit | -$46M |
Ebitda | -$44M |
Net Income | -$46M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Lucid Diagnostics Inc. is a commercial stage medical diagnostic technology company. The company is headquartered in New York, New York.